Literature DB >> 18086813

Comparison of the effects of Leishmania major or Leishmania donovani infection on macrophage gene expression.

David J Gregory1, Robert Sladek, Martin Olivier, Greg Matlashewski.   

Abstract

The intracellular parasite Leishmania causes a wide spectrum of human disease, ranging from self-resolving cutaneous lesions to fatal visceral disease, depending on the species of Leishmania involved. The mechanisms by which different Leishmania species cause different pathologies are largely unknown. We have addressed this question by comparing the gene expression profiles of bone marrow-derived macrophages infected with either Leishmania donovani or L. major promastigotes. We found that the two species had very similar effects on macrophage gene expression. Both species caused a small (<2.5-fold) but statistically significant repression of several hundred genes. In addition, both species strongly induced and repressed about 60 genes. Comparing the effects of the two species showed that only 26 genes were regulated differently by L. major as opposed to L. donovani, including those for metallothioneins 1 and 2, HSP70 and -72, CCL4, Gadd45beta, Dsp1, matrix metalloprotease 13, T-cell death-associated gene 51 (Tdag51), RhoB, spermine/spermidine N1-acyl transferase 1 (SSAT), and Cox2. L. donovani-infected macrophages were also found to express higher levels of Cox2 protein and prostaglandin E synthase mRNA than L. major-infected macrophages. While both species have previously been shown to trigger prostaglandin E synthesis by bystander cells, this study suggests that infected macrophages themselves express prostaglandin E-synthesizing genes only in response to L. donovani.

Entities:  

Mesh:

Year:  2007        PMID: 18086813      PMCID: PMC2258831          DOI: 10.1128/IAI.01320-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  A proline- and glutamine-rich protein promotes apoptosis in neuronal cells.

Authors:  I Gomes; W Xiong; T Miki; M R Rosner
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

2.  A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death.

Authors:  C G Park; S Y Lee; G Kandala; S Y Lee; Y Choi
Journal:  Immunity       Date:  1996-06       Impact factor: 31.745

3.  Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  Ji Zhou; Sárka Lhoták; Brooke A Hilditch; Richard C Austin
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

4.  Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.

Authors:  Rüdiger Neef; Martina A Kuske; Elma Pröls; Judith P Johnson
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.

Authors:  Claudine Matte; Martin Olivier
Journal:  J Infect Dis       Date:  2002-02-06       Impact factor: 5.226

6.  Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major.

Authors:  L A De Freitas; L M Mbow; M Estay; J A Bleyenberg; R G Titus
Journal:  Parasite Immunol       Date:  1999-05       Impact factor: 2.280

Review 7.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

8.  Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

Authors:  M Betz; B S Fox
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

9.  Combined treatment with interleukin-12 and indomethacin promotes increased resistance in BALB/c mice with established Leishmania major infections.

Authors:  Jian Li; Udaikumar M Padigel; Phillip Scott; Jay P Farrell
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Leishmania (Leishmania) chagasi infection alters the expression of cell adhesion and costimulatory molecules on human monocyte and macrophage.

Authors:  M C De Almeida; S A Cardoso; M Barral-Netto
Journal:  Int J Parasitol       Date:  2003-02       Impact factor: 3.981

View more
  32 in total

1.  Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.

Authors:  N S Geraci; J C Tan; M A McDowell
Journal:  Parasite Immunol       Date:  2015-01       Impact factor: 2.280

2.  Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.

Authors:  Alok Kumar Singh; Rajeev Kumar Pandey; Jair Lage Siqueira-Neto; Yong-Jun Kwon; Lucio H Freitas-Junior; Chandrima Shaha; Rentala Madhubala
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

3.  Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction.

Authors:  Michelle A Favila; Nicholas S Geraci; Erliang Zeng; Brent Harker; David Condon; Rachel N Cotton; Asha Jayakumar; Vinita Tripathi; Mary Ann McDowell
Journal:  J Immunol       Date:  2014-05-07       Impact factor: 5.422

4.  Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines.

Authors:  Shuyi Zhang; Charles C Kim; Sajeev Batra; James H McKerrow; P'ng Loke
Journal:  PLoS Negl Trop Dis       Date:  2010-03-30

Review 5.  Interference with nuclear factor kappaB signaling pathway by pathogen-encoded proteases: global and selective inhibition.

Authors:  Andrea Hodgson; Fengyi Wan
Journal:  Mol Microbiol       Date:  2015-11-05       Impact factor: 3.501

6.  Protection of macrophages from intracellular pathogens by miR-182-5p mimic-a gene expression meta-analysis approach.

Authors:  David J Gregory; Igor Kramnik; Lester Kobzik
Journal:  FEBS J       Date:  2017-12-26       Impact factor: 5.542

7.  Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.

Authors:  Maria Adelaida Gómez; Adriana Navas; Ricardo Márquez; Laura Jimena Rojas; Deninson Alejandro Vargas; Victor Manuel Blanco; Roni Koren; Dan Zilberstein; Nancy Gore Saravia
Journal:  J Antimicrob Chemother       Date:  2013-08-24       Impact factor: 5.790

8.  Human macrophage response to L. (Viannia) panamensis: microarray evidence for an early inflammatory response.

Authors:  Carolina Ramírez; Yira Díaz-Toro; Jair Tellez; Tiago M Castilho; Ricardo Rojas; Nicholas A Ettinger; Irina Tikhonova; Neal D Alexander; Liliana Valderrama; Janet Hager; Mary E Wilson; Aiping Lin; Hongyu Zhao; Nancy G Saravia; Diane McMahon-Pratt
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

Review 9.  Determinants for the development of visceral leishmaniasis disease.

Authors:  Laura-Isobel McCall; Wen-Wei Zhang; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

10.  Transcriptomic signature of Leishmania infected mice macrophages: a metabolic point of view.

Authors:  Imen Rabhi; Sameh Rabhi; Rym Ben-Othman; Axel Rasche; Adriani Daskalaki; Bernadette Trentin; David Piquemal; Béatrice Regnault; Albert Descoteaux; Lamia Guizani-Tabbane
Journal:  PLoS Negl Trop Dis       Date:  2012-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.